Celeste Krewson, Assistant Editor

A recent study reported the link between antenatal corticosteroid timing and the 5 and a half-year survival and neurological outcomes in preterm children, highlighting the importance of evaluating and optimizing the interval between administration and birth for improved long-term results.

Intrapartum antibiotic prophylaxis for Group B Streptococcus (GBS) during labor induction not only reduces clinical chorioamnionitis but also decreases peripartum infectious morbidity, suggesting potential broader applications for tailored prophylaxis beyond GBS-positive cases.

A recent study reveals that hysterectomy without an adnexal surgical procedure increases the risk of osteoporosis among women aged 40 to 59 years, emphasizing the need for informed patient consultation regarding this potential association.

New study suggests maternal migration background impacts survival rates for infants born extremely preterm, underscoring the need to address disparities in birth outcomes and investigate potential connections between immigration status and perinatal health.

A recent study unveiled a novel screening method, utilizing validated questionnaires to accurately identify myofascial urinary frequency syndrome in patients with lower urinary tract symptoms.

Recent CDC data reveals a substantial decrease in cigarette smoking during pregnancy from 2016 to 2022 across all race and ethnic groups, emphasizing positive strides in maternal and fetal health.

Agile Therapeutics has provided insights on strengthening the Affordable Care Act's contraceptive coverage, with a recent House Committee report revealing barriers, inequalities, and recommended changes.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reveals that relugolix combination therapy demonstrates sustained reduction in menstrual bleeding volume for women with symptomatic uterine fibroids.

A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.

Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.

The Supreme Court's upcoming decision on mifepristone, a key abortion medication, may alter access, introducing potential restrictions and impacting the landscape of abortion rights.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.

Toby Maurer, MD, professor at University of California, San Francisco, discusses dermatologic conditions commonly seen in pediatric patients.

Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.

Toby Maurer, MD, professor at University of California, San Francisco, discusses common skin conditions seen in female patients, along with the best methods of treating these conditions.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.

A recent study highlights significant disparities in kidney transplant and nephrology care access for pregnant patients with end-stage kidney disease, revealing reduced survival rates and limited access to crucial care compared to non-pregnancy-related causes.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.

A recent study revealed vaginal progesterone offers no significant reduction in preterm birth risk for twin gestations, prompting reconsideration of its proposed efficacy.

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Findings from a nationwide study in Sweden revealed a reduction in pregnancy weight gain among women with a history of bariatric surgery, underscoring potential clinical implications.

Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.

New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.

Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.

Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.

Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.

A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.

A recent study reveals gaps in reproductive health services for women with disabilities, highlighting a 69% likelihood of encountering barriers, including logistical and access challenges.